Literature DB >> 2163364

Synovial sarcoma: an immunohistochemical and ultrastructural study.

N G Ordóñez1, S M Mahfouz, B Mackay.   

Abstract

Thirty-nine primary synovial sarcomas (15 biphasic, 24 monophasic), and 19 metastatic synovial sarcomas were studied with a battery of antibodies directed to keratin, epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), vimentin, desmin, muscle-specific actin, smooth muscle actin, S-100 protein, Leu-7, chromogranin A, laminin, collagen IV, Ulex europaeus agglutinin I (UEAI), and the HMB-45 antimelanoma antibody. Twenty-two primary and 18 metastatic synovial sarcomas were also examined by electron microscopy. Epithelial and/or spindle cells in every biphasic tumor, primary and metastatic, reacted for keratin and EMA, but only six primary tumors (five biphasic and one monophasic) showed weak reactivity for CEA which, in the biphasic tumors, was confined to the epithelial component. Of the monophasic tumors, 15 primary (63%) and four metastatic (25%) stained for keratin, whereas seven primary (29%) and two metastatic (13%) tumors reacted for EMA. Only one primary monophasic synovial sarcoma stained for CEA. Tumors that stained for EMA or CEA also stained for keratin which is, therefore, the most useful epithelial marker. Immunostaining for epithelial markers, UEAI, collagen IV, and laminin serves to delineate the epithelial component when it is obscure in routine sections. Electron microscopy facilitates the diagnosis when epithelial markers are not expressed and aids in separating monophasic synovial sarcomas from other sarcomas that they resemble by light microscopy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163364     DOI: 10.1016/0046-8177(90)90034-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database.

Authors:  Jon Mallen-St Clair; Armin Arshi; Elliot Abemayor; Maie St John
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-06-01       Impact factor: 6.223

2.  Poorly differentiated synovial sarcoma: a case report.

Authors:  F Cappello; M Bellafiore; F Bucchieri; G Balsano; A Palma; G Zummo
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Epithelioid sarcoma: an electron-microscopic, immunohistochemical and DNA flow cytometric analysis.

Authors:  T Ishida; T Oka; H Matsushita; R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

4.  Synovial sarcoma of the sellar region.

Authors:  Bernd W Scheithauer; Ana Isabel Silva; Keith Kattner; Jason Seibly; Andre M Oliveira; Kalman Kovacs
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

5.  TRPA1 Expression in Synovial Sarcoma May Support Neural Origin.

Authors:  Francesco De Logu; Filippo Ugolini; Chiara Caporalini; Annarita Palomba; Sara Simi; Francesca Portelli; Domenico Andrea Campanacci; Giovanni Beltrami; Daniela Massi; Romina Nassini
Journal:  Biomolecules       Date:  2020-10-15

Review 6.  The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.

Authors:  Michele Fiore; Andrea Sambri; Paolo Spinnato; Riccardo Zucchini; Claudio Giannini; Emilia Caldari; Maria Giulia Pirini; Massimiliano De Paolis
Journal:  Curr Treat Options Oncol       Date:  2021-10-23

Review 7.  The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling.

Authors:  Valeriya Pankova; Khin Thway; Robin L Jones; Paul H Huang
Journal:  Front Cell Dev Biol       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.